XML 30 R15.htm IDEA: XBRL DOCUMENT v3.20.4
9. Outstanding Warrants
12 Months Ended
Dec. 31, 2020
Warrants and Rights Note Disclosure [Abstract]  
Outstanding Warrants

During the years ended December 31, 2020 and 2019, the Company granted 227 thousand common stock warrants, for the extension of certain Notes for each period, respectively. The accredited investors received 2-year warrants exercisable at $0.01 per share as part of note agreements.

 

The weighted average fair value calculations for warrants granted are based on the following weighted average assumptions:

 

Description   For the year ended December 31  
    2020     2019  
Dividend-yield     0 %     0 %
Risk-free interest rate     0.84 %     2.13 %
Expected volatility     108.8 %     103.0 %
Expected life (years)     2       2  
Market value per share on grant date   $ 0.81     $ 0.73  
Exercise price per share   $ 0.01     $ 0.01  
Fair value per share on grant date   $ 0.80     $ 0.72  

 

For the years ended December 31, 2020 and 2019, Note investors exercised 227 thousand warrant shares for each period respectively, at exercise prices of $0.01 per share, respectively.

 

A summary of historical warrant activity for the years ended December 31, 2020 and 2019 follows:

 

     Warrants Outstanding & Exercisable     Weighted - Average Exercise Price     Average Remaining Term in Years  
 Outstanding December 31, 2018     95     $ 2.59       6.95  
 Granted     227       0.01          
 Exercised     (227 )     0.01          
 Outstanding December 31, 2019     95     $ 2.59       5.95  
 Granted     227       0.01          
 Exercised     (227 )     0.01          
 Outstanding December 31, 2020     95     $ 2.59       4.95  

 

All of the above outstanding warrants are vested and exercisable as of December 31, 2020. As of December 31, 2020 and 2019, the Company had no unrecognized compensation expense related to warrants, respectively.